Jessica S. Little, MD (she/her/hers)

Transplant Infectious Diseases Physician
Brigham and Women's Hospital
Boston, MA, United States

Dr. Jessica Little is an Instructor at Harvard Medical School and Associate Physician in the Division of Infectious Diseases at Brigham and Women’s Hospital and Dana-Farber Cancer Institute. She also serves as Associate Medical Director of Antimicrobial Stewardship. Her clinical and research focus lies in infections among immunocompromised hosts, particularly those undergoing hematopoietic cell transplantation and CAR T-cell therapy. Dr. Little is actively involved in clinical trials investigating novel therapeutic agents and vaccines for infections in immunocompromised patients.

Disclosure(s): Merck and Company, Inc.: Grant/Research Support; Moderna, Inc.: Grant/Research Support

Presentation(s):

• 90 - Interim Assessment of Safety and Immunogenicity From a Proof-of-Concept Phase 2 Trial of an mRNA-Based Cytomegalovirus Vaccine in Patients Who Have Undergone Allogeneic Hematopoietic Cell Transplantation

  Monday, October 20, 2025
  11:30 AM - 11:43 AM US ET

• 81 - Challenging Consults in Clinical Mycology

  Monday, October 20, 2025
  3:15 PM - 4:30 PM US ET

• 401 - Host, treatment, and disease-related risk factors for invasive fungal disease in 549 patients with newly diagnosed high-risk myeloid malignancies treated with intensive induction chemotherapy

  Tuesday, October 21, 2025
  2:45 PM - 2:57 PM US ET

• 210 - T-Cell Modifying Therapies: What the ID Provider Needs to Know

  Wednesday, October 22, 2025
  10:30 AM - 11:45 AM US ET

• 579 - Not All CARs and Abs Are Created Equal: Incidence, Type and Timing of Infections

  Wednesday, October 22, 2025
  10:55 AM - 11:20 AM US ET